Spots Global Cancer Trial Database for ipss intermediate 1
Every month we try and update this database with for ipss intermediate 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Efficacy and Safety of 5-day Dosing of ON 01910.Na in Intermediate-1,-2, or High Risk Myelodysplastic Syndrome (MDS) | NCT00867061 | Myelodysplastic... | ON 01910.Na Con... | 18 Years - | Traws Pharma, Inc. |